Category Archives: Food & Drug Recalls

Mei Shun Noodle, Inc. Issues Allergy Alert on Undeclared Shellfish and Soy in Rice Noodles

Mei Shun Noodle, Inc. of Chicago, IL, is recalling its 12 ounce packages of 6毛FIVE branded Rice Noodles. During inspection by the Illinois Department of Public Health, we found that some of the product was mislabeled. The products may contain dried, salted shrimp and soy, which are not included on the label.
Read The Complete Story!

Kellogg Company Voluntarily Recalls Limited Number of Kellogg’s® Eggo® Nutri-Grain® Whole Wheat Waffles Due to Potential Health Risk

Kellogg Company is voluntarily recalling approximately 10,000 cases of Kellogg’s® Eggo® Nutri-Grain® Whole Wheat Waffles because they have the potential to be contaminated with Listeria monocytogenes. No other Eggo products are impacted by this recall.
Read The Complete Story!

Ferrara Candy Issues Allergy Alert on Undeclared Peanuts and Wheat in Almond Supremes with a Best by Date of 4/22/2017

Ferrara Candy Company has initiated a voluntary recall of Brach’s® 5 ounce Almond Supremes with a best by date of 4/22/2017 after discovering that some Brach’s® Almond Supremes packages may include Brach’s® Bridge Mix, a product that contains peanuts and wheat. No other Ferrara Candy Company products are affected.
Read The Complete Story!

Censea, Inc. Recalls Shrimp Product Because of Possible Health Risk

Censea, Inc. is recalling its A-PAC 8/12 count Headless Shell on Black Tiger Shrimp, because it has the potential to be contaminated with Salmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhea (which may be bloody), nausea, vomiting and abdominal pain. In rare circumstances, infection with Salmonella can result in the organism getting into the bloodstream and producing more severe illnesses such as arterial infections (i.e., infected aneurysms), endocarditis and arthritis.

FDA grants accelerated approval to first drug for Duchenne muscular dystrophy

The U.S. Food and Drug Administration today approved Exondys 51 (eteplirsen) injection, the first drug approved to treat patients with Duchenne muscular dystrophy (DMD). Exondys 51 is specifically indicated for patients who have a confirmed mutation of the dystrophin gene amenable to exon 51 skipping, which affects about 13 percent of the population with DMD.

FDA protects kids from illegal sales of e-cigarettes, e-liquids and cigars

The U.S. Food and Drug Administration announced today it has taken action against 55 tobacco retailers by issuing the first warning letters for selling newly regulated tobacco products, such as e-cigarettes, e-liquids and cigars, to minors. These actions come about a month after the FDA began enforcing new federal regulations making it illegal nationwide to sell e-cigarettes, cigars, hookah tobacco, and other newly regulated tobacco products to anyone under age 18 in person and online, and requiring retailers to check photo ID of anyone under age 27, among other restrictions.